These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 27100297)
1. Prognostic Value of SUVmax Measured by Pretreatment Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Ewing Sarcoma. Hwang JP; Lim I; Kong CB; Jeon DG; Byun BH; Kim BI; Choi CW; Lim SM PLoS One; 2016; 11(4):e0153281. PubMed ID: 27100297 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of SUVmax measured by pretreatment 18F-FDG PET/CT in patients with primary gastric lymphoma. Hwang JP; Lim I; Byun BH; Kim BI; Choi CW; Lim SM Nucl Med Commun; 2016 Dec; 37(12):1267-1272. PubMed ID: 27482643 [TBL] [Abstract][Full Text] [Related]
3. Response to chemotherapy estimates by FDG PET is an important prognostic factor in patients with Ewing sarcoma. Raciborska A; Bilska K; Drabko K; Michalak E; Chaber R; Pogorzała M; Połczyńska K; Sobol G; Wieczorek M; Muszyńska-Rosłan K; Rychlowska-Pruszyńska M; Rodriguez-Galindo C; Dziuk M Clin Transl Oncol; 2016 Feb; 18(2):189-95. PubMed ID: 26250765 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value of SUVmax measured by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography in Patients with Pancreatic Cancer. Hwang JP; Lim I; Chang KJ; Kim BI; Choi CW; Lim SM Nucl Med Mol Imaging; 2012 Sep; 46(3):207-14. PubMed ID: 24900062 [TBL] [Abstract][Full Text] [Related]
5. Post-treatment FDG PET/CT predicts progression-free survival in young patients with small round blue cell tumors: Ewing sarcoma and PNET. Sobic Saranovic DP; Nikitovic M; Saponjski J; Grozdic Milojevic I; Paripovic L; Saranovic D; Beatovic S; Artiko VM Eur J Radiol; 2020 Aug; 129():109076. PubMed ID: 32446127 [TBL] [Abstract][Full Text] [Related]
6. [Prognostic value of pretreatment (18)F-FDG PET-CT for patients with advanced diffuse large B-cell lymphoma]. Ding CY; Guo Z; Sun J; Yang WP; Li TR Zhonghua Zhong Liu Za Zhi; 2018 Jul; 40(7):528-533. PubMed ID: 30060362 [No Abstract] [Full Text] [Related]
7. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma. Cacicedo J; Fernandez I; Del Hoyo O; Navarro A; Gomez-Iturriaga A; Pijoan JI; Martinez-Indart L; Escudero J; Gomez-Suarez J; de Zarate RO; Perez JF; Bilbao P; Rades D Clin Transl Oncol; 2017 Nov; 19(11):1337-1349. PubMed ID: 28540535 [TBL] [Abstract][Full Text] [Related]
8. Volume-Based F-18 FDG PET/CT Imaging Markers Provide Supplemental Prognostic Information to Histologic Grading in Patients With High-Grade Bone or Soft Tissue Sarcoma. Andersen KF; Fuglo HM; Rasmussen SH; Petersen MM; Loft A Medicine (Baltimore); 2015 Dec; 94(51):e2319. PubMed ID: 26705220 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of metabolic parameters measured by pretreatment dual-time-point 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with intrahepatic or perihilar cholangiocarcinoma: A STROBE study. Hwang JP; Moon JH; Kim HK; Lee MH; Lim CH; Park SB; Yoon JK; Park JM Medicine (Baltimore); 2021 May; 100(21):e26015. PubMed ID: 34032720 [TBL] [Abstract][Full Text] [Related]
10. The prognostic value of SUV Diao W; Tian F; Jia Z Eur J Radiol; 2018 Aug; 105():1-7. PubMed ID: 30017264 [TBL] [Abstract][Full Text] [Related]
11. The preoperative SUVmax for (18)F-FDG uptake predicts survival in patients with colorectal cancer. Shi D; Cai G; Peng J; Li D; Li X; Xu Y; Cai S BMC Cancer; 2015 Dec; 15():991. PubMed ID: 26689966 [TBL] [Abstract][Full Text] [Related]
12. The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas. Palmerini E; Colangeli M; Nanni C; Fanti S; Marchesi E; Paioli A; Picci P; Cambioli S; Donati D; Cevolani L; De Paolis M; Gambarotti M; Ferrari S Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):215-223. PubMed ID: 27645694 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer. Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369 [TBL] [Abstract][Full Text] [Related]
15. [Prognostic value of preoperative positron emission tomography-computed tomography in surgically resected gastric cancer]. Kim KS; Choi SR; Park IC; Koo TH; Kim JM Korean J Gastroenterol; 2014 Jun; 63(6):348-53. PubMed ID: 24953611 [TBL] [Abstract][Full Text] [Related]
16. Large cell neuroendocrine carcinoma of the lung: CT and FDG PET findings. Lee KW; Lee Y; Oh SW; Jin KN; Goo JM Eur J Radiol; 2015 Nov; 84(11):2332-8. PubMed ID: 26279139 [TBL] [Abstract][Full Text] [Related]
17. Semi-Quantitative Calculations of Primary Tumor Metabolic Activity Using F-18 FDG PET/CT as a Predictor of Survival in 92 Patients With High-Grade Bone or Soft Tissue Sarcoma. Andersen KF; Fuglo HM; Rasmussen SH; Petersen MM; Loft A Medicine (Baltimore); 2015 Jul; 94(28):e1142. PubMed ID: 26181552 [TBL] [Abstract][Full Text] [Related]
18. Clinical and Prognostic Role of 18F-FDG PET/CT in Pediatric Ewing Sarcoma. Albano D; Dondi F; Schumacher RF; D'Ippolito C; Porta F; Giubbini R; Bertagna F J Pediatr Hematol Oncol; 2020 Mar; 42(2):e79-e86. PubMed ID: 31135716 [TBL] [Abstract][Full Text] [Related]
19. Can FDG-PET/CT replace blind bone marrow biopsy of the posterior iliac crest in Ewing sarcoma? Kasalak Ö; Glaudemans AWJM; Overbosch J; Jutte PC; Kwee TC Skeletal Radiol; 2018 Mar; 47(3):363-367. PubMed ID: 29124298 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of (18)F-fluorodeoxyglucose uptake before treatment for pharyngeal cancer. Suzuki H; Kato K; Fujimoto Y; Itoh Y; Hiramatsu M; Naganawa S; Hasegawa Y; Nakashima T Ann Nucl Med; 2014 May; 28(4):356-62. PubMed ID: 24515867 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]